Navigation Links
Myriant Technologies LLC Announces Appointment of Science Advisory Board Members

QUINCY, Mass., Oct. 21 /PRNewswire/ -- Myriant Technologies LLC (Myriant), a privately-held, biotech developer and manufacturer of renewable biochemicals, announced the formation of its Science Advisory Board and the appointment of distinguished Board members. Board members individually and collectively will provide broad insight into all aspects of the technology and business of converting renewable biomass feedstocks into valuable chemicals.

(Logo: )

Collectively, the Board members have outstanding credentials as scientists in the biotechnology fields of specific interest to Myriant, including: molecular biology, genetic and metabolic pathway engineering, micro-organism development and related fermentation process development.

Myriant's Science Advisory Board members include:

  • Dr. Stephen J. Benkovic, Evan Pugh Professor and Eberly Chair in Chemistry at Penn State University, and member of the National Academy of Sciences and its Institute of Medicine;
  • Dr. Joseph Glas, Executive Vice President and Advisory Board Chairman, Myriant;
  • Dr. Lonnie Ingram, Distinguished Professor, Department of Microbiology and Cell Science, University of Florida, and Director, Florida Center for Renewable Chemicals and Fuels, and member of the National Academy of Sciences;
  • Dr. Jan Westpheling, Professor, Department of Genetics, University of Georgia; and
  • Dr. Huimin Zhao, Professor, Centennial Endowed Chair of Chemical and Biomolecular Engineering, University of Illinois.

"I am honored and we are fortunate to have such an exceptional group of scientists as advisors to Myriant," said Stephen J. Gatto, Chairman and Chief Executive Officer of Myriant. "Under the leadership of Dr. Joe Glas, I have great confidence that we will reap immediate and long term benefits from their advice and input."

"The pace of change in Myriant's field of industrial biotechnology is ever accelerating," added Dr. Glas. "Our cutting-edge research and development team will benefit enormously from the addition of this unique expertise and its impact on our paths to commercialization."

With a world-renowned team of molecular biologists, engineers and chemists, Myriant utilizes proprietary technology to advance the development of low-cost cellulosic sugars for the sustainable commercialization of high-value specialty chemicals. The company's D(-) lactic acid started production at commercial scale in June 2008 for use in polylactic acid. Myriant will begin commercial production of its second product, biobased succinic acid, in 2010. Myriant is headquartered in Quincy, Massachusetts. Further information is available at

    Contact: Samuel G. McConnell
    Sr. VP, Corporate Development

SOURCE Myriant Technologies LLC

SOURCE Myriant Technologies LLC
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. BioEnergy International, LLC Announces Formation of Myriant Technologies LLC
2. China Medical Technologies to Exhibit its Products at China International Medical Equipment Fair in Chengdu, China
3. Epeius Biotechnologies to Partner at BIO Investor Forum
4. Neurobiological Technologies Announces Intent to File Form 25 to Delist Common Stock From the NASDAQ Capital Market
5. OriGene Technologies Acquires Marligen Biosciences
6. China Medical Technologies Announces the SFDA Approval for its SPR System
7. Global Med Technologies(R), Inc. Licenses EdgeLab to Seven Laboratories at University Hospital of Reims, France
8. Varian, Inc. Announces Stockholder Approval of Merger Agreement With Agilent Technologies
9. TOPAZ Technologies Protocols for Animal Studies Software Drives Customer Conversions
10. Global Med Technologies(R) Signs Binding LOI With European Company for Breakthrough Transfusion Safety RFID Product
11. Variation Biotechnologies Names Jeff Baxter CEO
Post Your Comments:
(Date:11/24/2015)... Inc., a worldwide provider of clinical research services headquartered in ... has set a new quarterly earnings record in Q3 of 2015.  ... Q3 of 2014 to Q3 of 2015.   ... the establishment of an Asia-Pacific office to ... and Mexico , with the establishment ...
(Date:11/24/2015)... Massachusetts , November 24, 2015 SHPG ... will participate in the Piper Jaffray 27 th Annual Healthcare ... Tuesday, December 1, 2015, at 8:30 a.m. EST (1:30 p.m. GMT). ... , Chief Financial Officer, will participate in the Piper Jaffray 27 ... , NY on Tuesday, December 1, 2015, at 8:30 a.m. ...
(Date:11/24/2015)... , Nov. 24, 2015  Twist Bioscience, ... that Emily Leproust, Ph.D., Twist Bioscience chief executive ... Healthcare Conference on December 1, 2015 at 3:10 ... in New York City. --> ... . Twist Bioscience is on Twitter. Sign ...
(Date:11/24/2015)... , Nov. 24, 2015 /CNW Telbec/ - ProMetic Life Sciences ... today that Mr. Pierre Laurin , President and Chief ... at the upcoming Piper Jaffray 27 th Annual Healthcare ... on December 1-2, 2015. st , at ... one-on-one meetings throughout the day. The presentation will be available ...
Breaking Biology Technology:
(Date:11/12/2015)... 11, 2015   Growing need for low-cost, ... has been paving the way for use of ... discrete analytes in clinical, agricultural, environmental, food and ... used in medical applications, however, their adoption is ... to continuous emphasis on improving product quality and ...
(Date:11/10/2015)... Nov. 10, 2015 About ... that helps to identify and verify the identity ... considered as the secure and accurate method of ... a particular individual because each individual,s signature is ... especially when dynamic signature of an individual is ...
(Date:11/4/2015)... --> --> ... Transparency Market Research "Home Security Solutions Market - Global Industry ... 2022", the global home security solutions market is expected to reach ... market is estimated to expand at a CAGR of ... Rising security needs among customers at homes, the emergence ...
Breaking Biology News(10 mins):